In 1Q16, LabCorp’s (LH) national clinical laboratory business, LabCorp Diagnostics, accounted for 69.3% of the company’s total revenues. Despite facing the impact of about -0.6% in revenues on a ...
Hosted on MSN
LH Q3 Deep Dive: Labcorp Sees Diagnostic Growth, Eyes Specialty Testing and Efficiency Initiatives
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) in Q3 CY2025, with sales up 8.6% year on year to $3.56 billion. Its non-GAAP profit of $4.18 per share was 1% above analysts’ consensus ...
Zacks Investment Research on MSN
HOLX vs. LH: Which medtech stock is the stronger investment now?
Hologic HOLX and Labcorp LH are two established MedTech players with a history of collaboration, though each brings distinct strengths. With a market capitalization of $16.71 billion, Hologic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback